This inventor holds 1 USPTO granted patent. Top assignee: University of Liverpool. Active years: 2006.
Company Filing History:
Years Active: 2006
Title: Brian Kevin Park: Innovator in Anti-Malarial Compounds
Introduction
Brian Kevin Park is a notable inventor based in Liverpool, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of anti-malarial compounds. His work is crucial in the ongoing fight against malaria, a disease that affects millions worldwide.
Latest Patents
Brian Kevin Park holds a patent for anti-malarial compounds. The present invention relates to pharmaceutical compounds for use in the treatment or prophylaxis of malaria. These compounds have a general formula where R is selected from a group consisting of dimethylamino, diethylamino, di-N-propylamino, diisopropylamino, di-N-butylamino, di-sec-butylamino, piperidinyl, piperizinyl, ethylamino, and tert-butylamino. Additionally, X is selected from a group consisting of chloro, fluoro, iodo, bromo, trifluoromethyl, methoxy, and methyl.
Career Highlights
Brian Kevin Park is affiliated with the University of Liverpool, where he conducts his research and development work. His innovative approach to creating effective anti-malarial treatments has garnered attention in the scientific community.
Collaborations
Some of his notable coworkers include Paul Michael O'Neill and Stephen Andrew Ward. Their collaborative efforts contribute to the advancement of research in the field of pharmaceuticals.
Conclusion
Brian Kevin Park is a dedicated inventor whose work in anti-malarial compounds is making a significant impact in the fight against malaria. His contributions to pharmaceutical innovation are vital for improving health outcomes globally.